ProMIS Neurosciences Inc (PMN): Next-Year EPS Estimate 28.12%
As of 2026-11-12, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 28.12%. Featured in our EPS revision report on 2026-07-30.
On 2026-10-30, analyst consensus for PMN's next-year EPS growth shifted from 26.51% to 28.12% — a positive change of 1.61 percentage points. The revised estimate has been sustained across 12 subsequent trading sessions. Current-year growth is projected at 77.43%.
What's Driving This
PMN’s rise appears primarily tied to the 2026-10-12 analyst revision, which raised the next-year EPS growth estimate from 25.36
Generated 2026-10-21 from news as of 2026-10-21
Current Snapshot
- Sector
- Healthcare
- Industry
- Biotechnology
- EPS growth next year
- 28.12%
- EPS growth this year
- 77.43%
- EPS next quarter (est)
- -$1.28
- Last price
- $3.48
EPS Revision History
| Date | EPS Next Y | EPS This Y | Next Q (est) | Price |
|---|---|---|---|---|
| 2026-11-12 | 28.12% | 77.43% | -$1.28 | $3.48 |
| 2026-11-11 | 28.12% | 77.43% | -$1.28 | $3.76 |
| 2026-11-10 | 28.12% | 77.43% | -$1.28 | $3.98 |
| 2026-11-09 | 28.12% | 77.43% | -$1.28 | $4.05 |
| 2026-11-07 | 28.12% | 77.43% | -$1.28 | $4.16 |
| 2026-11-06 | 28.12% | 77.43% | -$1.28 | $4.16 |
| 2026-11-05 | 28.12% | 77.43% | -$1.28 | $3.65 |
| 2026-11-04 | 28.12% | 77.43% | -$1.28 | $3.52 |
| 2026-11-03 | 28.12% | 77.43% | -$1.28 | $3.41 |
| 2026-11-02 | 28.12% | 77.43% | -$1.28 | $3.00 |
| 2026-10-31 | 28.12% | 77.43% | -$1.28 | $3.31 |
| 2026-10-30 | 28.12% | 77.43% | -$1.28 | $3.31 |
| 2026-10-29 | 26.51% | 77.67% | -$1.25 | $11.08 |
| 2026-10-28 | 26.51% | 77.67% | -$1.25 | $11.07 |
| 2026-10-27 | 26.51% | 77.67% | -$1.25 | $9.68 |
| 2026-10-26 | 26.51% | 77.67% | -$1.25 | $8.06 |
| 2026-10-23 | 26.51% | 77.67% | -$1.25 | $8.34 |
| 2026-10-22 | 26.51% | 77.67% | -$1.25 | $8.98 |
| 2026-10-21 | 26.51% | 77.67% | -$1.25 | $9.13 |
| 2026-10-20 | 26.51% | 77.67% | -$1.25 | $8.09 |
| 2026-10-19 | 26.51% | 77.67% | -$1.25 | $8.23 |
| 2026-10-16 | 26.51% | 77.67% | -$1.25 | $8.15 |
| 2026-10-15 | 26.51% | 77.67% | -$1.25 | $8.70 |
| 2026-10-14 | 26.51% | 77.67% | -$1.25 | $8.28 |
| 2026-10-13 | 26.51% | 77.67% | -$1.25 | $8.66 |
| 2026-10-12 | 26.51% | 77.67% | -$1.25 | $9.45 |
| 2026-10-11 | 25.36% | 77.42% | -$1.27 | $9.61 |
| 2026-10-10 | 25.36% | 77.42% | -$1.27 | $9.61 |
| 2026-10-09 | 25.36% | 77.42% | -$1.27 | $9.61 |
| 2026-10-08 | 25.36% | 77.42% | -$1.27 | $9.15 |
Reports Featuring PMN
Recent News
- ProMIS Neurosciences Inc (PMN) (Q2 2026) Earnings Call Highlights: Zero ARIA-E Cases and ...GuruFocus.com
- ProMIS Neurosciences Announces Second Quarter 2026 Financial Results and Provides Corporate HighlightsGlobeNewswire
- ProMIS Neurosciences to Host Webinar to Discuss Upcoming 6-Month Blinded Interim Data from PRECISE-AD Phase 1b Trial of PMN310 in Alzheimer's DiseaseGlobeNewswire
Screen Performance
Aggregate stats across all 2145 tickers our top-EPS-revision screen has flagged over the past 225 days.
- Median return since detection
- -2.9%
- % of tickers in the green
- 43%
- Median return on winners
- +22.8%
- Large revisions captured
- 2246
Past detection performance reflects the price change between when a ticker first entered our screen and the most recent observation. Not a forward-looking forecast.
Also Tracked by Our Screen
Frequently Asked Questions
What is ProMIS Neurosciences Inc's next-year EPS growth estimate?▾
As of 2026-11-12, ProMIS Neurosciences Inc (PMN) has a next-year EPS growth estimate of 28.12%, based on analyst consensus.
When was the latest EPS estimate revision for PMN?▾
The most recent revision occurred on 2026-10-30, when analysts adjusted the next-year EPS growth estimate from 26.51% to 28.12%.
What sector and industry does ProMIS Neurosciences Inc belong to?▾
ProMIS Neurosciences Inc operates in the Healthcare sector, specifically the Biotechnology industry.
How often is this EPS estimate data updated?▾
EPS revision data is refreshed daily from analyst consensus estimates. PMN appears on this page because it was flagged by our daily top-EPS-revision-performer screen.
EPS revision data sourced from analyst consensus estimates, refreshed daily. ProMIS Neurosciences Inc (PMN) appears here because it was detected by our daily top-EPS-revision-performer screen.